On Thursday, Progyny Inc (PGNY) stock saw a decline, ending the day at $15.55 which represents a decrease of $-0.31 or -1.95% from the prior close of $15.86. The stock opened at $15.84 and touched a ...

In a report released yesterday, Faisal Khurshid from Leerink Partners reiterated a Buy rating on Kymera Therapeutics (KYMR – Research ...

The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...

Pfizer and Merck's pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up ...

Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been given a consensus recommendation of “Hold” by ...

Read more: Swiss healthcare partners clinch new tariff system with flat rates This content was published on Oct 23, 2024 The International Monetary Fund has revised Switzerland’s growth forecast ...

Leerink Partners analyst Puneet Souda maintained a Hold rating on Twist Bioscience (TWST – Research Report) on October 22. The ...

Dentsply Sirona said on Thursday it was voluntarily suspending sales and marketing of its Byte teeth aligners and Impression Kits as it conducts a review of certain regulatory requirements related to ...

An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple ...

Fintel reports that on October 24, 2024, Leerink Partners initiated coverage of Tenax Therapeutics (NasdaqCM:TENX) with a ...

Viking Therapeutics (VKTX) stock gains 18% on strong Q3 results and promising updates on its obesity drug candidate VK2735.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 12.84% ...